Cargando…
Emerging Novel Combined CAR-T Cell Therapies
SIMPLE SUMMARY: As a result of FDA approval of CAR-T cell treatments in the last few years, this immunotherapy has provided further direction to precision medicine through its combination with other therapeutic approaches. In the past year, several review articles have been published focusing on adv...
Autores principales: | Nguyen, Anh, Johanning, Gary, Shi, Yihui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945996/ https://www.ncbi.nlm.nih.gov/pubmed/35326556 http://dx.doi.org/10.3390/cancers14061403 |
Ejemplares similares
-
Chimeric antigen receptor T-cell immunotherapy in breast cancer: development and challenges
por: Toulouie, Sara, et al.
Publicado: (2021) -
Combination therapy: A feasibility strategy for CAR-T cell therapy in the treatment of solid tumors
por: Xu, Jinjing, et al.
Publicado: (2018) -
Insight into the Progress in CAR-T Cell Therapy and Combination with Other Therapies for Glioblastoma
por: Liang, Tingyu, et al.
Publicado: (2023) -
CAR-T cell combination therapy: the next revolution in cancer treatment
por: Al-Haideri, Maysoon, et al.
Publicado: (2022) -
The Emerging Role of CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma
por: Meier, Jeremy A., et al.
Publicado: (2022)